Notoginsenoside R1 ameliorates diabetic encephalopathy by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation

Yadong Zhai(Ministry of Education of the People's Republic of China), Xiaobo Sun(Chinese Academy of Medical Sciences & Peking Union Medical College)
Oncotarget
January 16, 2018
Cited by 77


Related Papers